Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )
Clinical trial NCT04863079 · UNKNOWN
Trial details
- NCT number
- NCT04863079
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2022-04-30
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.